NIH launches study to collect samples for future disease breakthroughs

NCT ID NCT03253705

Recruiting now Knowledge-focused Sponsor: National Institutes of Health Clinical Center (CC) Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 4 times

Summary

This study collects blood and urine samples from healthy adults and patients with heart, lung, or blood vessel conditions. Researchers will use these samples to study genes, proteins, and other substances in the lab. The goal is to support basic and translational research that could lead to new discoveries. Participants provide samples during short visits, and no treatment is given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide valuable samples that help researchers develop new tests or treatments for heart, lung, and blood vessel diseases.
What could go wrong: This is a sample-collection study, not a treatment trial. It does not directly test any therapy, so it may not lead to immediate medical breakthroughs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arteriosclerosis disorder infectious disease with sepsis pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOTHELIAL DYSFUNCTION HEALTHY VOLUNTEERS INFLAMMATION IN CARDIOPULMONARY AND VASCULAR DISEASE STATES

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.